Please login to the form below

Not currently logged in
Email:
Password:

cardiac

This page shows the latest cardiac news and features for those working in and with pharma, biotech and healthcare.

Novartis’ heart failure drug Entresto proves superior to enalapril

Novartis’ heart failure drug Entresto proves superior to enalapril

It does this by inhibiting harmful effects of the overactive renin-angiotensin-aldosterone system (RAAS), a pathologic consequence of ill cardiac function.

Latest news

More from news
Approximately 1 fully matching, plus 163 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics